glp-1 concentration Stop stalling your progress by making these common dosing mistakes. 🛑 When it comes to GLP-1s, more isn't always better: and faster definitely isn't better. We're seeing too many people rush through GLP-1-directed NMDA receptor antagonism for

If you experience side effects or have concerns, talk to your healthcare provider or pharmacist about what you are experiencing and ways to manage it

These tend to follow the same pattern as nausea, peaking during titration and decreasing over time

The incretin-based mechanism of action for these agents causes them to suppress glucagon in a glucose-dependent fashion while simultaneously inducing insulin secretion

Pro: Lixisenatide is the only GLP analog that does not have a boxed warning about the risk of thyroid C-cell tumors

For patients prescribed cannabis-based medicinal products (such as those for epilepsy, chemotherapy-induced nausea, or chronic pain), prescribers should be informed of concurrent tirzepatide use

Incretins and Gastrointestinal Hormones: Pathophysiology and Pre-analytical Considerations